Chronic kidney disease, stage 3a
ICD-10 N18.31 is a billable code used to indicate a diagnosis of chronic kidney disease, stage 3a.
Chronic kidney disease (CKD) stage 3a is characterized by a moderate decrease in kidney function, with an estimated glomerular filtration rate (eGFR) ranging from 45 to 59 mL/min/1.73 m². This stage indicates that the kidneys are not filtering waste effectively, leading to potential complications such as hypertension, anemia, and bone disease. Patients may remain asymptomatic, but some may experience symptoms like fatigue, swelling, or changes in urination. Management typically involves controlling underlying conditions such as diabetes and hypertension, dietary modifications, and regular monitoring of kidney function. Patients in this stage are at increased risk for progression to more severe stages of CKD, necessitating careful management and follow-up. It is crucial for healthcare providers to document the stage accurately, as it influences treatment decisions and potential referrals for renal replacement therapy or transplantation in the future.
Detailed documentation of kidney function tests, co-morbidities, and treatment plans.
Management of CKD with hypertension and diabetes, preparation for dialysis or transplant.
Ensure accurate staging of CKD and documentation of all relevant lab results.
Regular monitoring of kidney function, management of risk factors, and patient education.
Routine follow-up of CKD patients, management of complications.
Document lifestyle modifications and adherence to treatment plans.
Used to monitor kidney function in CKD patients.
Document lab results and interpretation.
Nephrology may require more frequent monitoring.
CKD stage 3a indicates moderate kidney dysfunction, which requires careful management to prevent progression to more severe stages and associated complications.
